News Puma gains as Roche breast cancer combo disappoints ASCO serves up shock as Roche's data disappoints
News ASCO to shine light on CAR-T developments Kite, Juno, and BlueBird will give updates on T-cell therapies.
Views & Analysis ASCO 2017: Breast cancer next target for Keytruda Immunotherapy combinations will be the focus - but attention is shifting towards these agents proving their overall survival benefits.
Views & Analysis Tunnah’s musings: Lessons for pharma from digital ASCO 2016 Pharma needs to remedy its approach to digital conference engagement.
Views & Analysis A European perspective on oncology: ASCO review An overview of the latest on immunotherapies, progress in multiple myeloma and benefits of patient-reported outcomes.
Views & Analysis Digital healthcare round-up: ASCO apps, public health, weara... A round-up of this week's top digital healthcare news. Marco Ricci reports.
News CHMP decision levels the playing field for GSK's RSV jab GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
